Abstract:BACKGROUND Gastric cancer (GC) is one of the most common and deadliest types of cancer worldwide due to its delayed diagnosis and high metastatic frequency, but its exact pathogenesis has not been fully elucidated. ETS homologous factor (EHF) is an important member of the ETS family and contributes to the pathogenesis of multiple malignant tumors. To date, whether EHF participates in the development of GC via the c-Met signaling pathway remains unclear. AIM To investigate the role and mechanism of EHF in the occurrence and development of GC. METHODS The expression of EHF mRNA in GC tissues and cell lines was measured by quantitative PCR. Western blotting was performed to determine the protein expression of EHF, c-Met, and its downstream signal molecules. The EHF expression in GC tissues was further detected by immunohistochemical staining. To investigate the role of EHF in GC oncogenesis, small interfering RNA (siRNA) against EHF was transfected into GC cells. The cell proliferation of GC cells was determined by Cell Counting Kit-8 and colony formation assays. Flow cytometry was performed following Annexin V/propidium iodide (PI) to identify apoptotic cells and PI staining to analyze the cell cycle. Cell migration and invasion were assessed by transwell assays. RESULTS The data showed that EHF was upregulated in GC tissues and cell lines in which increased expression of c-Met was also observed. Silencing of EHF by siRNA reduced the proliferation of GC cells. Inhibition of EHF induced significant apoptosis and cell cycle arrest in GC cells. Cell migration and invasion were significantly inhibited. EHF silencing led to c-Met downregulation and further blocked the Ras/c-Raf/extracellular signal-related kinase 1/2 (Erk1/2) pathway. Additionally, phosphatase and tensin homolog was upregulated and glycogen synthase kinase 3 beta was deactivated. Moreover, inactivation of signal transducer and activator of transcription 3 was detected following EHF inhibition, leading to inhibition of the epithelial-to-mesenchymal transition (EMT). CONCLUSION These results suggest that EHF plays a key role in cell proliferation, invasion, apoptosis, the cell cycle and EMT via the c-Met pathway. Therefore, EHF may serve as an antineoplastic target for the diagnosis and treatment of GC.

Targeting Cadherin-17 Inactivates Ras/Raf/MEK/ERK Signaling and Inhibits Cell Proliferation in Gastric Cancer

Cadherin-17 Induces Tumorigenesis and Lymphatic Metastasis in Gastric Cancer Through Activation of NFκB Signaling Pathway

ADAM17 Promotes Epithelial-Mesenchymal Transition Via TGF-β/Smad Pathway in Gastric Carcinoma Cells

Blockage of ETS Homologous Factor Inhibits the Proliferation and Invasion of Gastric Cancer Cells Through the C-Met Pathway

Overexpression of ERα Inhibits Proliferation and Invasion of MKN28 Gastric Cancer Cells by Suppressing Β-Catenin

Protocadherin 17 Acts As a Tumour Suppressor Inducing Tumour Cell Apoptosis and Autophagy, and is Frequently Methylated in Gastric and Colorectal Cancers

Association Between Cadherin-17 Expression and Pathological Characteristics of Gastric Cancer: A Meta-Analysis

Blockade of Proliferation and Migration of Gastric Cancer Via Targeting CDH17 with an Artificial Microrna

Circ-104916 is downregulated in gastric cancer and suppresses migration and invasion of gastric cancer cells.

PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer

Keratin17 Promotes Tumor Growth and is Associated with Poor Prognosis in Gastric Cancer

Pcdh17 Gene Promoter Demethylation and Cell Cycle Arrest by Genistein in Gastric Cancer

Lentiviral-Mediated Mirna Against Liver-Intestine Cadherin Suppresses Tumor Growth And Invasiveness Of Human Gastric Cancer

Histidine-rich calcium binding protein promotes gastric cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition through Raf/MEK/ERK signaling

CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway

Cantharidin suppresses gastric cancer cell migration/invasion by inhibiting the PI3K/Akt signaling pathway via CCAT1.

Hmga2 Regulates Cd44 Expression to Promote Gastric Cancer Cell Motility and Sphere Formation

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer

Protocadherin-8 Promotes Invasion and Metastasis Via Laminin Subunit Γ2 in Gastric Cancer.

MicroRNA-17 Inhibition Overcomes Chemoresistance and Suppresses Epithelial-Mesenchymal Transition Through a DEDD-dependent Mechanism in Gastric Cancer.

KBTBD2 promotes proliferation and migration of gastric cancer via activating EGFR signaling pathway